Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Albiruni Ryan Abdul Razak

Determinants of the Recommended Phase 2 Dose of Molecular Targeted Agents

Cancer Research

English

Related publications

Clinical Benefit in Phase-I Trials of Novel Molecularly Targeted Agents: Does Dose Matter?

British Journal of Cancer

Cancer Research

English

Recommended Dose of Anti-D Immunoglobulin.

English

Recommended Environmental Dose Calculation Methods and Hanford-Specific Parameters. Revision 2

English

Delayed Adverse Events in Phase I Trials of Molecularly Targeted and Cytotoxic Agents

English

A Dose-Escalating Phase I of Imatinib Mesylate With Fixed Dose of Metronomic Cyclophosphamide in Targeted Olid Tumours

British Journal of Cancer

Cancer Research

English

Molecular Targeted Agents--Where We Are and Where We Are Going

Chinese Journal of Cancer

English

A Phase I Clinical Trial of Targeted Intraoperative Molecular Imaging for Pulmonary Adenocarcinomas

Annals of Thoracic Surgery

Respiratory Medicine

Cardiovascular Medicine

English

New BNF Maximum Recommended Dose for Haloperidol

Psychiatric Bulletin

English

Unmasking the Molecular Determinants Important for Ca 2+ -Dependent Regulation of Ca v 2.2

Biophysical Journal

English